2023 Was a tricky yr for the biopharma field, with many companies downsizing and restructuring their workforces to stay afloat. You'll find indications of Restoration, as mergers and acquisitions picked up over the pharmaceutical and existence sciences business in the latter Element of 2023 and have continued their upswing into https://sites.google.com/view/bio-sites/blog